Werewolf Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HOWL and other ETFs, options, and stocks.

About HOWL

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. 

CEO
Daniel J. Hicklin
CEODaniel J. Hicklin
Employees
39
Employees39
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2017
Founded2017
Employees
39
Employees39

HOWL Key Statistics

Market cap
20.52M
Market cap20.52M
Price-Earnings ratio
-0.35
Price-Earnings ratio-0.35
Dividend yield
Dividend yield
Average volume
772.19K
Average volume772.19K
High today
$0.4399
High today$0.4399
Low today
$0.365
Low today$0.365
Open price
$0.365
Open price$0.365
Volume
2.99M
Volume2.99M
52 Week high
$2.38
52 Week high$2.38
52 Week low
$0.27
52 Week low$0.27

Stock Snapshot

With a market cap of 20.52M, Werewolf Therapeutics(HOWL) trades at $0.41. The stock has a price-to-earnings ratio of -0.35.

As of 2026-07-25, Werewolf Therapeutics(HOWL) stock has fluctuated between $0.37 and $0.44. The current price stands at $0.41, placing the stock +12.4% above today's low and -6.8% off the high.

The Werewolf Therapeutics(HOWL)'s current trading volume is 2.99M, compared to an average daily volume of 772.19K.

In the last year, Werewolf Therapeutics(HOWL) shares hit a 52-week high of $2.38 and a 52-week low of $0.27.

In the last year, Werewolf Therapeutics(HOWL) shares hit a 52-week high of $2.38 and a 52-week low of $0.27.

People also own

Based on the portfolios of people who own HOWL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.